erectile%20dysfunction
ERECTILE DYSFUNCTION

Erectile dysfunction is the inability to attain and maintain an erection enough to have satisfactory sexual performance for ≥3 months.

It is when the patient complains of partial erection that could not attain vaginal penetration.

Complete loss of penile rigidity is uncommon.

Initial penile erections can penetrate but early detumescence occurs without ejaculation.

Patient Education

Patient & Partner Education

  • Some men may only need reassurance that decline in sexual function is due to aging, medication or chronic illnesses & is not necessarily a sign of serious illness
    • They may refuse treatment
  • Education & reassurance may help in preventing further erectile failure due to the above causes
  • Discuss w/ patient & partner (if possible) the important treatment options & their associated risks & benefits
  • Cultural, religious & economic factors should be taken into consideration
  • The choice of treatment should be decided together by physician, patient & partner

Lifestyle Modification

  • Modifying possible risk factors may be helpful
    • Resolving partner relationship issues
    • Smoking cessation
    • Reduce alcohol/drug abuse
    • Regular exercise and weight management
Editor's Recommendations
Most Read Articles
Pearl Toh, 10 Jul 2018
A dual-hormone artificial pancreas (DAP) with a rapid delivery of insulin and pramlintide in a fixed ratio improves glycaemic control and reduces glucose variability in adults with type 1 diabetes (T1D) compared with first-generation artificial pancreas delivering insulin alone, according to a study presented at ADA 2018.
4 days ago
Chocolate consumption is not associated with risk of coronary heart disease (CHD), stroke or both combined in postmenopausal women free of pre-existing major chronic disease, a study suggests.
Pearl Toh, 5 days ago
More intensive lowering of LDL-C levels was associated with a progressively greater survival benefit than less intensive approach, when the baseline LDL-C levels were ≥100 mg/dL, reveals a meta-analysis of 34 randomized trials.
4 days ago
Switching from thiazide diuretic to ipragliflozin, a sodium-glucose co-transporter 2 (SGLT2) inhibitor, leads to improvements in metabolic parameters and body mass composition without affecting blood pressure in type 2 diabetes (T2D) patients, a recent study has found.